Home › Funds › Nextech Invest Ltd. › CTMX
Nextech Invest Ltd. position in CTMX
CYTOMX THERAPEUTICS INC. · Health Care
Nextech Invest Ltd. reported holding 4,449,932 shares of CTMX (CYTOMX THERAPEUTICS INC.) in its Q2 2026 13F filing — a position valued at US$16.7M, representing 0.79% of its reported portfolio and ranking #11 among its reported holdings. Nextech Invest Ltd. has disclosed CTMX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Nextech Invest Ltd.'s CTMX position evolved
Nextech Invest Ltd. first disclosed a stake in CTMX in Q1 2026 at 4,449,932 shares (US$20.9M). Across 2 filings, Nextech Invest Ltd. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 4,449,932 shares valued at US$16.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 4.45M | $20.91M | New |
| Q2 2026 | 4.45M | $16.69M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CTMX and 13F data
CTMX (CYTOMX THERAPEUTICS INC.) is a Health Care company. 45 other funds we track also report a position in CTMX — the largest reported positions include Kynam Capital Management, LP (US$81.4M), PERCEPTIVE ADVISORS LLC (US$39.1M), Venrock Adviser, LLC (US$18.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CTMX
- Kynam Capital Management, LP 21.70M sh · $81.39M · Q2 2026
- PERCEPTIVE ADVISORS LLC 10.44M sh · $39.15M · Q2 2026
- Venrock Adviser, LLC 4.98M sh · $18.68M · Q2 2026
- Elmind Capital, LP 4.55M sh · $17.06M · Q2 2026
- Eversept Partners, LP 3.56M sh · $13.34M · Q2 2026
- ADAR1 Capital Management, LLC 3.37M sh · $12.62M · Q2 2026
- Seven Fleet Capital Management LP 1.09M sh · $4.07M · Q2 2026
- Ally Bridge Group (NY) LLC 775.00K sh · $2.91M · Q2 2026
More on Nextech Invest Ltd.
FAQ
How long has Nextech Invest Ltd. held CTMX?
Nextech Invest Ltd. has disclosed CTMX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Nextech Invest Ltd.'s current position in CTMX?
As of Q2 2026, Nextech Invest Ltd. holds 4.45M shares of CTMX (CYTOMX THERAPEUTICS INC.), valued at $16.69M, representing 0.79% of its reported portfolio and ranking #11.
Has Nextech Invest Ltd. been buying or selling CTMX?
In the latest 13F filing (Q2 2026), Nextech Invest Ltd. held unchanged its position in CTMX.
Which other funds hold CTMX?
Other major institutional holders of CTMX include Kynam Capital Management, LP, PERCEPTIVE ADVISORS LLC, Venrock Adviser, LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.